- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02088437
High Intensity Physiotherapy for Hip Fractures (HIP4hips)
High Intensity Physiotherapy for Hip Fractures in the Acute Hospital Setting
Every day, more than 40 Australian break their hip, Most are over the age of sixty five. Hip fractures are a significant problem for the older people, the hospital system and community as a whole because of the increasing numbers of fractures and the cost of hospitalisation and ongoing care. After one year, less than half of all people with a hip fracture can walk as well as they did before the fracture. Physiotherapy in the acute hospital setting is an integral part of patient care, although the intensity of physiotherapy a patient receives is variable and the optimal number of treatment sessions per day remains unknown. Studies in other patient groups have shown that increased physiotherapy can improve patient outcomes by increasing muscle strength and mobility. It can also reduce the negative effects of bed rest such as muscle wasting, blood clots in the lungs or leg veins and chest infections such as pneumonia. This study aims to investigate the effectiveness of an intensive physiotherapy program in hip fracture patients to further understand this and the effect it has on patient function.
In this research the investigators will randomly allocate patients into 2 groups; usual care and intensive physiotherapy. The usual care group will have physiotherapy treatment daily whereas the intensive physiotherapy group will have an additional daily treatment by a physiotherapist as well as a daily treatment by an allied health assistant. The objectives are to achieve better functional outcomes in the patient's hospital stay (ie improved mobility), reduce the time for patients to be physically ready to go home, increase the number of patients able to go directly home or to fast stream rehabilitation (rather than a slow stream option).
If increased intensity of physiotherapy is found to improve patient's mobility outcomes, this research will provide the confidence to endorse a change to current clinical practice.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Victoria
-
Melbourne, Victoria, Australia, 3181
- The Alfred
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Admission to The Alfred with an isolated hip fracture and treated with internal fixation, aged 65 or above
Exclusion Criteria:
- fracture is in the sub-trochanteric region of the femur,
- if it is pathological,
- if post operative orders are for non-weight bearing on the operated hip,
- if they were unable to mobilise independently (or with gait aid) prior to admission,
- or if they were admitted from a nursing home.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Usual care
usual care physiotherapy - once daily treatment whilst inpatient in acute hospital
|
once daily physiotherapy whilst acute hospital inpatient
|
|
Sperimentale: Intensive physiotherapy
additional once daily physiotherapy and once daily allied health assistant intervention
|
additional once daily physiotherapy and once daily allied health assistant intervention (equals two more treatments) whilst an inpatient in acute hospital
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
modified IOWA Level of Assistance Scale
Lasso di tempo: 5 days
|
Functional score measuring 6 mobility domains
|
5 days
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
length of stay - acute and rehabilitation
Lasso di tempo: participants will be followed for duration of hospital stay - average one month
|
the length of acute hospital stay and rehabilitation stay - until discharge home or to a long term facility
|
participants will be followed for duration of hospital stay - average one month
|
|
timed up and go
Lasso di tempo: 5 days
|
5 days
|
|
|
Glasgow Outcomes Score -Extended
Lasso di tempo: 6 months
|
6 months
|
|
|
discharge destination
Lasso di tempo: participants will be followed until discharge from the acute hospital - average 10 days
|
discharge destination from the acute hospital - options include: home, fast stream rehabilitation, slow stream rehabilitation, long term facility
|
participants will be followed until discharge from the acute hospital - average 10 days
|
|
physical readiness for discharge
Lasso di tempo: average one month
|
when a patient is deemed physically ready go home - eg can access their house and mobilise within house and outdoors
|
average one month
|
|
12-Item Short Form Health Survey (SF-12)
Lasso di tempo: 6 months
|
6 months
|
|
|
EuroQOL five dimensions questionnaire (EQ-5D)
Lasso di tempo: 6 months
|
6 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Lara A Kimmel, B.Physio, The Alfred
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 32/14
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .